138 related articles for article (PubMed ID: 34973392)
21. Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action.
Fernández-Montalván AE; Berger M; Kuropka B; Koo SJ; Badock V; Weiske J; Puetter V; Holton SJ; Stöckigt D; Ter Laak A; Centrella PA; Clark MA; Dumelin CE; Sigel EA; Soutter HH; Troast DM; Zhang Y; Cuozzo JW; Keefe AD; Roche D; Rodeschini V; Chaikuad A; Díaz-Sáez L; Bennett JM; Fedorov O; Huber KVM; Hübner J; Weinmann H; Hartung IV; Gorjánácz M
ACS Chem Biol; 2017 Nov; 12(11):2730-2736. PubMed ID: 29043777
[TBL] [Abstract][Full Text] [Related]
22. ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE.
Guruvaiah P; Chava S; Sun CW; Singh N; Penn CA; Gupta R
Cell Death Dis; 2023 Jul; 14(7):456. PubMed ID: 37479754
[TBL] [Abstract][Full Text] [Related]
23. ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway.
Sun T; Du B; Diao Y; Li X; Chen S; Li Y
BMB Rep; 2019 Jul; 52(7):457-462. PubMed ID: 31186081
[TBL] [Abstract][Full Text] [Related]
24. Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells.
Morozumi Y; Boussouar F; Tan M; Chaikuad A; Jamshidikia M; Colak G; He H; Nie L; Petosa C; de Dieuleveult M; Curtet S; Vitte AL; Rabatel C; Debernardi A; Cosset FL; Verhoeyen E; Emadali A; Schweifer N; Gianni D; Gut M; Guardiola P; Rousseaux S; Gérard M; Knapp S; Zhao Y; Khochbin S
J Mol Cell Biol; 2016 Aug; 8(4):349-62. PubMed ID: 26459632
[TBL] [Abstract][Full Text] [Related]
25. ATAD2 silencing decreases VEGFA secretion through targeting has-miR-520a to inhibit angiogenesis in colorectal cancer.
Hong S; Chen S; Wang X; Sun D; Yan Z; Tai J; Bi M
Biochem Cell Biol; 2018 Dec; 96(6):761-768. PubMed ID: 29958090
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
Ge T; Liu T; Guo L; Chen Z; Lou G
Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
[TBL] [Abstract][Full Text] [Related]
27. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J
Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716
[TBL] [Abstract][Full Text] [Related]
28. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
29. Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells.
Yao D; You J; Yang X; Zhang J; Yao X
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2242601. PubMed ID: 37533352
[TBL] [Abstract][Full Text] [Related]
30. ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.
Liu Q; Liu H; Li L; Dong X; Ru X; Fan X; Wen T; Liu J
Int J Oncol; 2020 Jan; 56(1):219-231. PubMed ID: 31746426
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach.
Miller DC; Martin MP; Adhikari S; Brennan A; Endicott JA; Golding BT; Hardcastle IR; Heptinstall A; Hobson S; Jennings C; Molyneux L; Ng Y; Wedge SR; Noble MEM; Cano C
Org Biomol Chem; 2018 Mar; 16(11):1843-1850. PubMed ID: 29469144
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2).
Hong S; Bi M; Chen S; Zhao P; Li B; Sun D; Tai J
Neoplasma; 2016; 63(6):873-879. PubMed ID: 27565325
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
Li N; Yu Y; Wang B
Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
[TBL] [Abstract][Full Text] [Related]
34. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
Revenko AS; Kalashnikova EV; Gemo AT; Zou JX; Chen HW
Mol Cell Biol; 2010 Nov; 30(22):5260-72. PubMed ID: 20855524
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of microRNA-186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2.
Wu S; Han M; Zhang C
J Cell Physiol; 2019 Aug; 234(10):19059-19072. PubMed ID: 30993715
[TBL] [Abstract][Full Text] [Related]
36. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.
Sun W; Lan X; Zhang H; Wang Z; Dong W; He L; Zhang T; Zhang P; Liu J; Qin Y
Cell Death Dis; 2018 Mar; 9(3):380. PubMed ID: 29515109
[TBL] [Abstract][Full Text] [Related]
37. A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer.
Liu Q; Liu H; Huang X; Fan X; Xiao Z; Yan R; Yao J; An G; Ge Y; Miao J; Liu J
Cancer Gene Ther; 2023 Jan; 30(1):192-208. PubMed ID: 36151333
[TBL] [Abstract][Full Text] [Related]
38. ATAD2 interacts with C/EBPβ to promote esophageal squamous cell carcinoma metastasis via TGF-β1/Smad3 signaling.
Cao LJ; Zhang YJ; Dong SQ; Li XZ; Tong XT; Chen D; Wu ZY; Zheng XH; Xue WQ; Jia WH; Zhang JB
J Exp Clin Cancer Res; 2021 Mar; 40(1):109. PubMed ID: 33757572
[TBL] [Abstract][Full Text] [Related]
39. The ATAD2/ANCCA homolog Yta7 cooperates with Scm3
Shahnejat-Bushehri S; Ehrenhofer-Murray AE
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5386-5393. PubMed ID: 32079723
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic potential of ATAD2 in stomach cancer and insights into the protein-protein interactions at its AAA + ATPase domain and bromodomain.
Nayak A; Kumar S; Singh SP; Bhattacharyya A; Dixit A; Roychowdhury A
J Biomol Struct Dyn; 2022 Aug; 40(12):5606-5622. PubMed ID: 33438526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]